By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fox Chase Cancer Center 

333 Cottman Avenue

Philadelphia  Pennsylvania  19111-2497  U.S.A.
Phone: 888-369-2427 Fax: n/a




Company News
ReproCELL And Fox Chase Cancer Center Partner To Open Multi-Site Biosample Repository In India 5/25/2017 7:00:21 AM
Oncoceutics Release: Fox Chase Cancer Center Enrolling Patients In ONC201 Multiple Myeloma Trial 5/1/2017 10:02:06 AM
ReproCELL And Fox Chase Cancer Center Form Strategic Alliance To Accelerate Biomarker And Genetic Discovery 4/13/2017 11:51:23 AM
ERYtech Pharma Collaborates With Fox Chase Cancer Center To Advance Its Platform In The Field Of Rare Metabolic Disorders 3/23/2017 11:54:00 AM
Fox Chase Cancer Center Study: Pancreatic And Kidney Cancers Contain Noncancerous Niches That May Be Manipulated To Hinder Tumor Growth 1/31/2017 8:59:44 AM
Morphotek Announces Sponsored Research Agreement With Fox Chase Cancer Center To Study Immunosuppressive Effects Of Tumor Shed Antigens To Improve Future Patient Therapies 9/13/2016 9:31:49 AM
Fox Chase Cancer Center Researchers Use New Methodology To Identify Neighborhood Variables Associated With Prostate Cancer Aggressiveness 4/15/2016 9:19:24 AM
Review By Fox Chase Cancer Center -- Temple Health And Temple University School Of Medicine Physicians Highlights Advances In Diagnosis And Treatment Of Bile Ducts Cancers 1/22/2016 9:55:46 AM
Caris Life Sciences And Fox Chase Cancer Center - Temple Health Collaborate On Potential New Treatments For Triple-Negative Breast Cancer (TNBC) 12/8/2015 11:20:01 AM
Oncoceutics Release: Clinical Trial For ONC201 Begins At Fox Chase Cancer Center 11/30/2015 1:02:50 PM